Abstract
In this review we provide a brief background on the cell cycle and then focus on two novel and emerging areas of cell cycle research that may prove to have significant relevance to the development of novel anticancer agents. In particular, we review the emerging evidence to suggest that histone deacetylase inhibitors may possess cancer cell-specific cytotoxicity due to their ability to target a novel G2/M checkpoint. We also review the recent literature supporting the proposition that inhibition of E2F activity in epithelial cancer cells may prove to be a useful differentiation therapy that operates via cell cycle-dependent and cell cycleindependent mechanisms.
Keywords: angiogenesis, dna replication, mitosis, cyclin dependent kinase inhibitors, transcription, phosphorylation
Current Cancer Drug Targets
Title: Exploiting Novel Cell Cycle Targets in the Development of Anticancer Agents
Volume: 5 Issue: 2
Author(s): Chung Fai Wong, Alexander Guminski, Nicholas A. Saunders and Andrew J. Burgess
Affiliation:
Keywords: angiogenesis, dna replication, mitosis, cyclin dependent kinase inhibitors, transcription, phosphorylation
Abstract: In this review we provide a brief background on the cell cycle and then focus on two novel and emerging areas of cell cycle research that may prove to have significant relevance to the development of novel anticancer agents. In particular, we review the emerging evidence to suggest that histone deacetylase inhibitors may possess cancer cell-specific cytotoxicity due to their ability to target a novel G2/M checkpoint. We also review the recent literature supporting the proposition that inhibition of E2F activity in epithelial cancer cells may prove to be a useful differentiation therapy that operates via cell cycle-dependent and cell cycleindependent mechanisms.
Export Options
About this article
Cite this article as:
Wong Fai Chung, Guminski Alexander, Saunders A. Nicholas and Burgess J. Andrew, Exploiting Novel Cell Cycle Targets in the Development of Anticancer Agents, Current Cancer Drug Targets 2005; 5 (2) . https://dx.doi.org/10.2174/1568009053202090
DOI https://dx.doi.org/10.2174/1568009053202090 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Comparing the Efficacy and Safety of Dexmedetomidine/Ketamine with
Propofol/Fentanyl for Sedation in Colonoscopy Patients: A Doubleblinded
Randomized Clinical Trial
CNS & Neurological Disorders - Drug Targets Atrial Fibrillation in Patients Undergoing Surgical Revascularization: An Update on Pharmacologic Prophylaxis
Cardiovascular & Hematological Agents in Medicinal Chemistry Staphylococcus aureus: The Toxic Presence of a Pathogen Extraordinaire
Current Medicinal Chemistry Pharmacological Management of Psychosis in Parkinson Disease: A Review
Current Drug Therapy The Ignored Role of Intraoperative Hypotension in Producing Postoperative Acute Kidney Injury-An Obligatory Appeal for More Preventative Nephrology
Current Hypertension Reviews Native Proteins in Organic Chemistry. Recent Achievements in the use of non Hydrolytic Enzymes for the Synthesis of Pharmaceuticals
Current Organic Chemistry Melatonin, a Potential Therapeutic Agent for Smooth Muscle-Related Pathological Conditions and Aging
Current Medicinal Chemistry Ovarian Hyperstimulation Syndrome: The Best Approaches for Preven-tion and Treatment: A Mini-Review
Current Women`s Health Reviews Calcium-Independent Membrane Damage by Venom Phospholipases A2
Protein & Peptide Letters Immunotherapy in Bladder Cancer
Current Molecular Pharmacology An Overview of Olive Oil Biomolecules
Current Biotechnology Medical Gains of Chondroitin Sulfate Upon Fucosylation
Current Medicinal Chemistry Cell Cycle Inhibition in Malignant Lymphoma: Disease Control by Attacking the Cellular Proliferation Machinery
Current Drug Targets QT Prolongation and Anticancer Drugs: Is it a Cardiologist’s Worry? The Oncologist’s Point of View
Reviews on Recent Clinical Trials Anticholinesterase and Pharmacokinetic Profile of Phenserine in Healthy Elderly Human Subjects
Current Alzheimer Research Medication-Induced Nephrotoxicity in Older Patients
Current Drug Metabolism Pharmacogenomics and Sepsis-Induced Renal Failure: Effects of β 2-Adrenoceptor Function on the Course of Sepsis
Current Pharmacogenomics and Personalized Medicine Dopexamine After Heart Surgery: An Uncommonly Used, Though Useful Inotropic Agent
Recent Patents on Cardiovascular Drug Discovery Antifungal Agents in Hematopoietic Stem Cell Transplantation
Current Pharmaceutical Design An Efficient Multiple Kernel Support Vector Regression Model for Assessing Dry Weight of Hemodialysis Patients
Current Bioinformatics